Dr Kristine Saygan, MD | |
6220 W Bell Rd Ste 100c, Glendale, AZ 85308-3896 | |
(602) 547-7335 | |
Not Available |
Full Name | Dr Kristine Saygan |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 10 Years |
Location | 6220 W Bell Rd Ste 100c, Glendale, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114344678 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Honorhealth Urgent Care, Llc | 0345130266 | 93 |
News Archive
Breast cancer patients often wonder what their daughters might do to reduce their risk of also developing cancer. Are there dietary intakes or behaviors that can be modified by their daughters to lower their own chances of getting the disease? A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, sought information relevant to this question.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
News outlets examine how federal and state provisions on health care coverage set out an uneven landscape for low-income Americans, legal immigrants and those who came to the country illegally as children and who were given legal status for two-year periods.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.
Knee replacement patients go home sooner, are highly satisfied and incur less cost when a physician anesthesiologist coordinates care, suggests research presented at the ANESTHESIOLOGY™ 2014 annual meeting.
› Verified 2 days ago
Entity Name | Honorhealth Urgent Care, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740273614 PECOS PAC ID: 0345130266 Enrollment ID: O20040316000867 |
News Archive
Breast cancer patients often wonder what their daughters might do to reduce their risk of also developing cancer. Are there dietary intakes or behaviors that can be modified by their daughters to lower their own chances of getting the disease? A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, sought information relevant to this question.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
News outlets examine how federal and state provisions on health care coverage set out an uneven landscape for low-income Americans, legal immigrants and those who came to the country illegally as children and who were given legal status for two-year periods.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.
Knee replacement patients go home sooner, are highly satisfied and incur less cost when a physician anesthesiologist coordinates care, suggests research presented at the ANESTHESIOLOGY™ 2014 annual meeting.
› Verified 2 days ago
Entity Name | Honorhealth-fastmed Ambulatory Holdings Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467069047 PECOS PAC ID: 0244650505 Enrollment ID: O20201027000044 |
News Archive
Breast cancer patients often wonder what their daughters might do to reduce their risk of also developing cancer. Are there dietary intakes or behaviors that can be modified by their daughters to lower their own chances of getting the disease? A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, sought information relevant to this question.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
News outlets examine how federal and state provisions on health care coverage set out an uneven landscape for low-income Americans, legal immigrants and those who came to the country illegally as children and who were given legal status for two-year periods.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.
Knee replacement patients go home sooner, are highly satisfied and incur less cost when a physician anesthesiologist coordinates care, suggests research presented at the ANESTHESIOLOGY™ 2014 annual meeting.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kristine Saygan, MD 6220 W Bell Rd Ste 100c, Glendale, AZ 85308-3896 Ph: (602) 547-7335 | Dr Kristine Saygan, MD 6220 W Bell Rd Ste 100c, Glendale, AZ 85308-3896 Ph: (602) 547-7335 |
News Archive
Breast cancer patients often wonder what their daughters might do to reduce their risk of also developing cancer. Are there dietary intakes or behaviors that can be modified by their daughters to lower their own chances of getting the disease? A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, sought information relevant to this question.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
News outlets examine how federal and state provisions on health care coverage set out an uneven landscape for low-income Americans, legal immigrants and those who came to the country illegally as children and who were given legal status for two-year periods.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.
Knee replacement patients go home sooner, are highly satisfied and incur less cost when a physician anesthesiologist coordinates care, suggests research presented at the ANESTHESIOLOGY™ 2014 annual meeting.
› Verified 2 days ago
Jeremy Nebeker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18275 N 59th Avenue, Bldg K 162, Glendale, AZ 85308 Phone: 602-547-8184 Fax: 602-547-8339 | |
Ashwin Parekh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
John Mark Heyer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10150 N 67th Ave, Suite 101, Glendale, AZ 85302 Phone: 623-561-4547 Fax: 632-412-4995 | |
Ron Rosenwald, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6120 W Bell Rd Ste 110, Glendale, AZ 85308 Phone: 602-978-9053 Fax: 602-443-4570 | |
Michael S Underhill, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 18275 N 59th Avenue, Bldg K Ste 162, Glendale, AZ 85308 Phone: 602-547-8184 Fax: 602-547-8339 | |
Mr. Arthur N Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5757 W Thunderbird Road, Suite E-155, Glendale, AZ 85306 Phone: 623-247-1081 Fax: 623-247-2962 | |
Danielle L. Barnett-trapp, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19389 N 59th Ave, Glendale, AZ 85308 Phone: 236-537-6000 Fax: 623-537-6101 |